The “Aa3” rating affirmation is based on Scripps’ stable liquidity levels and history of strong operating performance.
Scripps also faces several challenges, including an increased debt load and high projected capital spending over the next few years.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Scripps’ operating performance will be sustained and that it will be able to fund the remainder of its capital program.
Scripps president and CEO Chris Van Gorder commented on the rating affirmation. “Moody’s affirmation of our rating and outlook is further indication of belief in Scripss’ ability to succeed in this new healthcare environment,” he said.
More articles on healthcare finance:
ER physicians criticize new Fla. law banning surprise medical charges
Post-acute care integration should be a priority for your hospital
UC-Berkeley School of Public Health mulls closing medical school program to cut costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
